Product Introduction:
Xilia Trio SR Tablet is a triple combination of Voglibose, Metformin, and Glimepiride. It works synergistically to control blood sugar in patients with type 2 diabetes mellitus. Voglibose reduces postprandial sugar spikes, Metformin improves insulin sensitivity and reduces glucose production in the liver, while Glimepiride stimulates insulin release from the pancreas.
Uses:
-
Type 2 Diabetes Mellitus
-
Management of both fasting and post-meal blood glucose levels
-
Helps in long-term diabetes control and prevention of complications
Benefits:
-
Triple-action control of blood glucose
-
Helps reduce insulin resistance and increase insulin secretion
-
Minimizes post-meal sugar spikes
-
Reduces the risk of diabetic complications when used consistently
Composition (per tablet):
-
Voglibose 0.2 mg
-
Metformin Hydrochloride (SR) 500 mg
-
Glimepiride 1 mg
Side Effects:
Common side effects may include:
-
Nausea or diarrhea (Metformin)
-
Low blood sugar (hypoglycemia) (Glimepiride)
-
Flatulence or abdominal discomfort (Voglibose)
-
Dizziness or headache
Seek immediate medical attention in case of severe hypoglycemia, persistent vomiting, or allergic reactions.
Safety Advice:
-
Take with meals to reduce gastrointestinal side effects and risk of low sugar
-
Monitor blood glucose regularly
-
Avoid alcohol consumption
-
Not recommended for use in type 1 diabetes or diabetic ketoacidosis
-
Store in a cool, dry place, away from sunlight
-
Keep out of reach of children
